Clinical trial
Quality of Life Study in Adults With Facial Eczema
NCT00120302 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00120302 |
|---|---|
| Title | Quality of Life Study in Adults With Facial Eczema |
| Official title | Quality of Life Study in Adults With Facial Eczema |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Pimecrolimus, Placebo |
| Enrollment | 76 |
| Start date | Mar 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Jul 15, 2005 |
| Last update posted | Jan 17, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: